[KO Validated] c-Myc Rabbit Monoclonal Antibody (CAB19032)
- SKU:
- CAB19032
- Product Type:
- Antibody
- Reactivity:
- Human
- Mouse
- Host Species:
- Rabbit
- Isotype:
- IgG
- Research Area:
- Epigenetics and Nuclear Signaling
Frequently bought together:
Description
Product Name: | [KO Validated] c-Myc Rabbit Monoclonal Antibody |
SKU: | CAB19032 |
Size: | 20uL, 100uL |
Isotype: | IgG |
Host Species: | Rabbit |
Reactivity: | Human,Mouse |
Immunogen: | A synthetic peptide corresponding to a sequence within amino acids 1-100 of human c-Myc (P01106). |
Sequence: | MPLN VSFT NRNY DLDY DSVQ PYFY CDEE ENFY QQQQ QSEL QPPA PSED IWKK FELL PTPP LSPS RRSG LCSP SYVA VTPF SLRG DNDG GGGS FSTA DQLE |
Tested Applications: | WB ChIP ELISA CUT&Tag |
Recommended Dilution: | WB,1:500 - 1:1000 ChIP,5μg antibody for 10μg-15μg of ChromatinCUT&Tag, 10⁵ cells /1 μg |
Synonyms: | MRTL; MYCC; c-Myc; bHLHe39; yc |
Positive Sample: | Jurkat, MCF7, HCT 116, Mouse ovary |
Conjugate: | Unconjugated |
Cellular Localization: | Nucleus, nucleolus, nucleoplasm. |
Calculated MW: | 51kDa |
Observed MW: | 50-60kDa |
This gene is a proto-oncogene and encodes a nuclear phosphoprotein that plays a role in cell cycle progression, apoptosis and cellular transformation. The encoded protein forms a heterodimer with the related transcription factor MAX. This complex binds to the E box DNA consensus sequence and regulates the transcription of specific target genes. Amplification of this gene is frequently observed in numerous human cancers. Translocations involving this gene are associated with Burkitt lymphoma and multiple myeloma in human patients. There is evidence to show that translation initiates both from an upstream, in-frame non-AUG (CUG) and a downstream AUG start site, resulting in the production of two isoforms with distinct N-termini.
Purification Method: | Affinity purification |
Gene ID: | 4609 |
Clone Number: | ARC0412 |
Storage Buffer: | Store at -20℃. Avoid freeze / thaw cycles.Buffer: PBS with 0.02% sodium azide,0.05% BSA,50% glycerol,pH7.3. |